On September 12, 2022 CANbridge Pharmaceuticals, Inc. (HKEX:1228) , a China and U.S.-based global biopharmaceutical company committed to the research, development and commercialization of transformative therapies to treat rare diseases and oncology, reported that it will be participating in two upcoming investor conferences (Press release, CANbridge Life Sciences, SEP 12, 2022, View Source [SID1234619462]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Morgan Stanley 20th Annual Global Healthcare Conference (New York)
CEO, James Xue, PhD, to participate in a fireside chat on Wednesday, September 14, 2022 at 4:05 PM EST
J.P. Morgan Global Healthcare Shanghai Conference (Shanghai)
September 26- 27